SCHEMBL9740353

SCHEMBL9740353

COc1ccc(C(=O)COc2ccc3oc(C(=O)c4ccc(OC)cc4)c(C)c3c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.58
ALDH1A1 P00352 7/20 0.58
MAPT P10636 7/20 0.58
SMN1; SMN2 Q16637 6/20 0.58
NPC1 O15118 5/20 0.58
RAB9A P51151 5/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
LMNA P02545 2/20 0.58
HSD17B10 Q99714 1/20 0.58
POLB P06746 3/20 0.57
HPGD P15428 2/20 0.54
TSHR P16473 1/20 0.54
ATM Q13315 1/20 0.54
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
TP53 P04637 1/20 0.50
TDP1 Q9NUW8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9741101 0.84 KDM4E (0.56) KDM4EALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL9727655 0.82 MAPT (0.61) KDM4EALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL716903 0.80 RAB9A (0.74) KDM4EALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL28417224 0.78 MEN1 (0.55) KDM4EALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL28420170 0.78 MEN1 (0.54) KDM4EALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL11823964 0.77 MAPT (0.73) KDM4EALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL9486652 0.77 HTT (0.64) KDM4EALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL4604031 0.76 MAPT (0.60) KDM4EALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL28209630 0.75 CASP3 (0.61) KDM4EALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL28411136 0.75 CASP3 (0.57) KDM4EALDH1A1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5087638-A Inhibitors of mammalian leukotriene biosynthesis MERCK FROSST CANADA, INC. (CA) 1992-02-11 US disclosed
EP-0338782-A1 Benzofuran derivatives MERCK FROSST CANADA INC. (CA) 1989-10-25 EP disclosed
US-4863958-A TREATING ALLERGIC CONDITIONS, ASTHMA, CARDIOVASCULAR DISORDERS, AND INFLAMMATION MERCK FROSST CANADA, INC. (CA) 1989-09-05 US disclosed
EP-0165810-B1 BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES, THEIR USE IN INHIBITING MAMMALIAN LEUKOTRIENE BIOSYNTHESIS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES MERCK FROSST CANADA INC. (CA) 1989-08-23 EP disclosed
EP-0165810-A2 Benzofuran and benzothiophene derivatives, their use in inhibiting mammalian leukotriene biosynthesis, and pharmaceutical compositions containing these derivatives MERCK FROSST CANADA INC. (CA) 1985-12-27 EP disclosed